Acacia Pharma Group PLC - ESG Rating & Company Profile powered by AI
This report of Acacia Pharma Group PLC uses information from across the internet and also from public documents by Acacia Pharma Group PLC. Jump to the bottom of the page for potential risks for Acacia Pharma Group PLC based on sector, geography and size. Other corporations in the rating peer group for Acacia Pharma Group PLC are shownin the table.
Acacia Pharma Group PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 2.0.
2.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1437 | Valenta Farmatsevtika AO | 2.7 | Medium |
| 1437 | Wockhardt Bio AG | 2.7 | Medium |
| 1481 | Acacia Pharma Group PLC | 2.6 | Medium |
| 1481 | CTI Biopharma Corp | 2.6 | Medium |
| 1481 | Cannara Biotech Inc | 2.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Acacia Pharma Group PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Acacia Pharma Group PLC report the average age of the workforce?
Sign up for free to unlockDoes Acacia Pharma Group PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Acacia Pharma Group PLC offer flexible work?
Sign up for free to unlockDoes Acacia Pharma Group PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Acacia Pharma Group PLC conduct supply chain audits?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Acacia Pharma Group PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose water use targets?
Sign up for free to unlockDoes Acacia Pharma Group PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Acacia Pharma Group PLC have a product recall in the last two years?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Acacia Pharma Group PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Acacia Pharma Group PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose parental leave metrics?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Acacia Pharma Group PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Acacia Pharma Group PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Acacia Pharma Group PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose its waste policy?
Sign up for free to unlockDoes Acacia Pharma Group PLC report according to TCFD requirements?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose energy use targets?
Sign up for free to unlockDoes Acacia Pharma Group PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Acacia Pharma Group PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Acacia Pharma Group PLC
These potential risks are based on the size, segment and geographies of the company.
Acacia Pharma Group plc, a hospital pharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, other invasive procedures, or cancer chemotherapy treatments in the United States and internationally. The company's lead product is BARHEMSYS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting. Its products also include BYFAVO, an ultra-short-acting and reversible intravenous sedative benzodiazepine for the use in invasive medical procedures, such as bronchoscopies and colonoscopies; and APD403, an intravenous and oral amisulpride that has completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting. The company's products are primarily serves anesthesiologists and oncologists. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom.